The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

USANA Health Sciences Inc

NYSE: USNA
Last

(U.S.) $59.35

Today's change+1.20 +2.06%
Updated February 21 4:02 PM EST. Delayed by at least 15 minutes.
 

USANA Health Sciences Inc

NYSE: USNA
Last

(U.S.) $59.35

Today's change+1.20 +2.06%
Updated February 21 4:02 PM EST. Delayed by at least 15 minutes.

USANA Health Sciences Inc up sharply

USANA Health Sciences Inc closed up sharply Tuesday, rallying (U.S.)$1.20 or 2.06% to (U.S.)$59.35. Over the last five days, shares have gained 1.54%, but are down 3.02% for the last year to date. Shares have underperformed the S&P 500 by 10.50% during the last year.

Key company metrics

  • Open(U.S.) $58.35
  • Previous close(U.S.) $58.15
  • High(U.S.) $59.40
  • Low(U.S.) $58.35
  • Bid / Ask(U.S.) $45.00 / (U.S.) $60.00
  • YTD % change-3.02%
  • Volume99,497
  • Average volume (10-day)179,785
  • Average volume (1-month)106,303
  • Average volume (3-month)119,163
  • 52-week range(U.S.) $52.98 to (U.S.) $75.00
  • Beta1.01
  • Trailing P/E14.86×
  • P/E 1 year forward14.23×
  • Forward PEG1.42×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $3.99
Updated February 21 4:02 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+9.94%

Based on its net profit margin of 9.94%, USANA Health Sciences Inc is less effective than other companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.53%Sector:Non-Cyclical Consumer Goods & ServicesIndustry:Personal Products

Latest Company News

View more News
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2016Q3/2016Q2/2016Q1/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201612/31/2016Oct 01, 201610/01/2016Jul 02, 201607/02/2016Apr 02, 201604/02/2016
Revenue253254259240
Total other revenue--------
Total revenue253254259240
Gross profit207209213198
Total cost of revenue46454643
Total operating expense221218221207
Selling / general / administrative175173175164
Research & development--------
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income32363734
Interest income (expense), net non-operating--000
Gain (loss) on sale of assets--------
Other--------
Income before tax32363833
Income after tax22302622
Income tax, total1061211
Net income22302622
Total adjustments to net income--------
Net income before extra. items22302622
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items22302622
Inc. avail. to common incl. extra. items22302622
Diluted net income22302622
Dilution adjustment--------
Diluted weighted average shares25252525
Diluted EPS excluding extraordinary itemsvalue per share0.871.201.030.89
Dividends per sharevalue per share--0.000.000.00
Diluted normalized EPSvalue per share0.871.201.030.89